Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir in Infants with Influenza LRTI
NCT01037634Phase 2Withdrawn
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2010
- Primary completion
- Mar 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of oseltamivir in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Planned start Mar 2010; status: withdrawn.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01037634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01037634.